Get started
Author

Yun Jeong Lee

Observed name: Seok-Yong Lee
Institution: Dankook University
ORCID: 0000-0002-7228-9558
Observed ORCIDs: 0000-0002-7228-9558, 0000-0003-4162-1981
OpenAlex ID: A5101420488
CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes
2018 · Ji-Young Byeon, Young-Hoon Kim, et al. · Archives of Pharmacal Research · 65
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite
2016 · Se-Hyung Kim, Do-Hoon Kim, et al. · Archives of Pharmacal Research · 49
Evaluation of medication use and pharmacy services for visually impaired persons: Perspectives from both visually impaired and community pharmacists
2018 · Bo Hee Lee, Yun Jeong Lee · Disability and health journal · 45
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
2021 · Young-Hoon Kim, Pureum Kang, et al. · Archives of Pharmacal Research · 40
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide
2020 · Jung-Woo Bae, Kyung-Yul Oh, et al. · Archives of Pharmacal Research · 40
Effect of icatibant on angiotensin‐converting enzyme inhibitor‐induced angioedema: A meta‐analysis of randomized controlled trials
2019 · Jinyoung Jeon, Yun Jeong Lee, et al. · Journal of Clinical Pharmacy and Therapeutics · 34
PDF
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan
2020 · Hyo-Bin Shin, Eui Hyun Jung, et al. · Archives of Pharmacal Research · 32
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes
2021 · Chang‑Keun Cho, Hye-Jung Park, et al. · Archives of Pharmacal Research · 29
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
2018 · Se-Hyung Kim, Ji-Young Byeon, et al. · Scientific Reports · 29
PDF
Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites
2018 · Mi-Jung Kim, Ji-Yeong Byeon, et al. · Archives of Pharmacal Research · 26
Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine
2018 · Ji-Yeong Byeon, Choong-Min Lee, et al. · Archives of Pharmacal Research · 25
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism
2022 · Chang‑Keun Cho, Pureum Kang, et al. · Archives of Pharmacal Research · 21
Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes
2020 · Eui Hyun Jung, Yun Jeong Lee, et al. · Archives of Pharmacal Research · 21
Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites
2018 · Hye-In Lee, Ji-Young Byeon, et al. · European Journal of Clinical Pharmacology · 21
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients
2021 · Eui Hyun Jung, Chang-Keun Cho, et al. · Archives of Pharmacal Research · 20
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes
2022 · Choong-Min Lee, Pureum Kang, et al. · Archives of Pharmacal Research · 19
Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects
2019 · Choong-Min Lee, Eui Hyun Jung, et al. · Archives of Pharmacal Research · 19
Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects
2021 · Nam-Tae Kim, Chang‑Keun Cho, et al. · Archives of Pharmacal Research · 18
Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele
2021 · Chang‑Keun Cho, Pureum Kang, et al. · Archives of Pharmacal Research · 18
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine
2024 · Chang-Keun Cho, Pureum Kang, et al. · Archives of Pharmacal Research · 16
The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem
2018 · Ji-Yeong Byeon, Young-Hoon Kim, et al. · Archives of Pharmacal Research · 16
Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects
2020 · Eui Hyun Jung, Choong-Min Lee, et al. · Archives of Pharmacal Research · 15
Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes
2018 · Ji-Yeong Byeon, Yun Jeong Lee, et al. · Archives of Pharmacal Research · 15
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes
2023 · Chang-Keun Cho, Pureum Kang, et al. · Archives of Pharmacal Research · 14
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
2022 · Chang‑Keun Cho, Ji-Young Byeon, et al. · Archives of Pharmacal Research · 14
Works count: 56
Citation count: 795
H-index: 18
I10-index: 31
Year
Topic
Type